Royal Bank of Canada’s Anika Therapeutics ANIK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$271K Sell
25,569
-1,811
-7% -$19.2K ﹤0.01% 4595
2025
Q1
$412K Sell
27,380
-15,629
-36% -$235K ﹤0.01% 3802
2024
Q4
$707K Sell
43,009
-6,017
-12% -$98.9K ﹤0.01% 3397
2024
Q3
$1.21M Sell
49,026
-135
-0.3% -$3.33K ﹤0.01% 3013
2024
Q2
$1.25M Buy
49,161
+1,049
+2% +$26.6K ﹤0.01% 2946
2024
Q1
$1.22M Sell
48,112
-4,086
-8% -$104K ﹤0.01% 2931
2023
Q4
$1.18M Buy
52,198
+2,406
+5% +$54.5K ﹤0.01% 3062
2023
Q3
$928K Sell
49,792
-877
-2% -$16.3K ﹤0.01% 3059
2023
Q2
$1.32M Buy
50,669
+5,482
+12% +$143K ﹤0.01% 2792
2023
Q1
$1.3M Buy
45,187
+16,122
+55% +$463K ﹤0.01% 2832
2022
Q4
$861K Sell
29,065
-10,749
-27% -$318K ﹤0.01% 3201
2022
Q3
$947K Sell
39,814
-798
-2% -$19K ﹤0.01% 3078
2022
Q2
$907K Buy
40,612
+1,377
+4% +$30.8K ﹤0.01% 3193
2022
Q1
$984K Sell
39,235
-3,520
-8% -$88.3K ﹤0.01% 3218
2021
Q4
$1.53M Buy
42,755
+304
+0.7% +$10.9K ﹤0.01% 2948
2021
Q3
$1.81M Buy
42,451
+1,115
+3% +$47.4K ﹤0.01% 2753
2021
Q2
$1.79M Buy
41,336
+562
+1% +$24.3K ﹤0.01% 2805
2021
Q1
$1.66M Sell
40,774
-10,734
-21% -$438K ﹤0.01% 2759
2020
Q4
$2.33M Buy
51,508
+1,141
+2% +$51.6K ﹤0.01% 2391
2020
Q3
$1.78M Buy
50,367
+447
+0.9% +$15.8K ﹤0.01% 2413
2020
Q2
$1.88M Buy
49,920
+1,460
+3% +$55.1K ﹤0.01% 2330
2020
Q1
$1.4M Buy
48,460
+2,483
+5% +$71.7K ﹤0.01% 2405
2019
Q4
$2.38M Sell
45,977
-2,577
-5% -$134K ﹤0.01% 2293
2019
Q3
$2.67M Sell
48,554
-28,092
-37% -$1.54M ﹤0.01% 2124
2019
Q2
$3.11M Buy
76,646
+25,827
+51% +$1.05M ﹤0.01% 2043
2019
Q1
$1.54M Buy
50,819
+8,208
+19% +$248K ﹤0.01% 2433
2018
Q4
$1.43M Sell
42,611
-2,133
-5% -$71.7K ﹤0.01% 2386
2018
Q3
$1.89M Buy
44,744
+3,143
+8% +$133K ﹤0.01% 2404
2018
Q2
$1.33M Sell
41,601
-7,155
-15% -$229K ﹤0.01% 2532
2018
Q1
$2.43M Buy
48,756
+2,030
+4% +$101K ﹤0.01% 2111
2017
Q4
$2.52M Sell
46,726
-686
-1% -$37K ﹤0.01% 2065
2017
Q3
$2.75M Buy
47,412
+7,462
+19% +$433K ﹤0.01% 1967
2017
Q2
$1.97M Sell
39,950
-471
-1% -$23.2K ﹤0.01% 2112
2017
Q1
$1.76M Buy
40,421
+2,658
+7% +$116K ﹤0.01% 2186
2016
Q4
$1.85M Buy
37,763
+776
+2% +$38K ﹤0.01% 2115
2016
Q3
$1.77M Sell
36,987
-1,343
-4% -$64.3K ﹤0.01% 2114
2016
Q2
$2.06M Buy
38,330
+12,224
+47% +$656K ﹤0.01% 2049
2016
Q1
$1.17M Sell
26,106
-11,704
-31% -$524K ﹤0.01% 2424
2015
Q4
$1.44M Buy
37,810
+198
+0.5% +$7.56K ﹤0.01% 2285
2015
Q3
$1.2M Buy
37,612
+310
+0.8% +$9.86K ﹤0.01% 2252
2015
Q2
$1.23M Buy
37,302
+10,171
+37% +$336K ﹤0.01% 2327
2015
Q1
$1.12M Buy
27,131
+1,000
+4% +$41.2K ﹤0.01% 2373
2014
Q4
$1.06M Buy
26,131
+9,256
+55% +$377K ﹤0.01% 2393
2014
Q3
$619K Buy
16,875
+225
+1% +$8.25K ﹤0.01% 2774
2014
Q2
$771K Sell
16,650
-150
-0.9% -$6.95K ﹤0.01% 2615
2014
Q1
$691K Buy
16,800
+400
+2% +$16.5K ﹤0.01% 2659
2013
Q4
$626K Buy
16,400
+413
+3% +$15.8K ﹤0.01% 2695
2013
Q3
$383K Sell
15,987
-1,013
-6% -$24.3K ﹤0.01% 3093
2013
Q2
$289K Buy
+17,000
New +$289K ﹤0.01% 3066